 or earworm. Previous clinical trials showed that 30% of patients experienced diarrhea. On WeGoV, the drug information leaflet distributed on Ozempic and WeGoV described diarrhea as very common side effect reported in more than 1 in 10 patients, which means it could be 20% or 30% or 40%, maybe half. We don't know.